U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 70

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr19:55665492
GRCh38:
Chr19:55154124
TNNI3D152GHypertrophic cardiomyopathy 7Likely pathogenic
(Feb 23, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr19:55667631
GRCh38:
Chr19:55156263
TNNI3R74CDilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy 7,
Dilated cardiomyopathy 1FF, Cardiomyopathy, Cardiovascular phenotype,
not provided, Hypertrophic cardiomyopathy
Uncertain significance
(Jun 1, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr19:55667645
GRCh38:
Chr19:55156277
TNNI3R69HHypertrophic cardiomyopathy 7Uncertain significance
(Jun 16, 2020)
no assertion criteria provided
4.
GRCh37:
Chr19:55663215
GRCh38:
Chr19:55151847
TNNI3K207RHypertrophic cardiomyopathy, Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy 7,
Dilated cardiomyopathy 2A, Dilated cardiomyopathy 1FF
Uncertain significance
(Aug 30, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr19:55667634
GRCh38:
Chr19:55156266
TNNI3G73RCardiomyopathy, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Uncertain significance
(Nov 8, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr19:55665481
GRCh38:
Chr19:55154113
TNNI3Q156EFamilial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy 7
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
7.
GRCh37:
Chr19:55673190
GRCh38:
Chr19:55161822
DNAAF3, DNAAF3-AS1, TNNI3R108S, R162S, R209S, R230SPrimary ciliary dyskinesia, Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Hypertrophic cardiomyopathy 7,
Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A
Uncertain significance
(Feb 2, 2018)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr19:55672066
GRCh38:
Chr19:55160698
DNAAF3, DNAAF3-AS1, TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A,
Hypertrophic cardiomyopathy 7
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
9.
GRCh37:
Chr19:55668422
GRCh38:
Chr19:55157054
TNNI3A35DFamilial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy 7
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr19:55663158
GRCh38:
Chr19:55151790
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy 7
Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
11.
GRCh37:
Chr19:55669002
GRCh38:
Chr19:55157634
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 1FF,
Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A,
Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy 7
Uncertain significance
(Aug 18, 2021)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr18:34261506
GRCh38:
Chr18:36681543
FHOD3I473T, I648THypertrophic cardiomyopathy 7Uncertain significance
(Jan 23, 2020)
criteria provided, single submitter
13.
GRCh37:
Chr19:55668434
GRCh38:
Chr19:55157066
TNNI3T31MCardiomyopathy, Cardiovascular phenotype, Hypertrophic cardiomyopathy,
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Dilated cardiomyopathy 1FF
Uncertain significance
(Sep 17, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr19:55666134
GRCh38:
Chr19:55154766
TNNI3A116GCardiomyopathy, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Uncertain significance
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr19:55668422
GRCh38:
Chr19:55157054
TNNI3A35VCardiomyopathy, Dilated cardiomyopathy 1FF, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy
Uncertain significance
(Apr 7, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr19:55668006-55668007
GRCh38:
Chr19:55156638-55156639
TNNI3S39fsHypertrophic cardiomyopathy, not provided, Cardiomyopathy,
Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 1FF,
Hypertrophic cardiomyopathy 7
Uncertain significance
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr19:55665590
GRCh38:
Chr19:55154222
TNNI3not provided, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 1FF,
Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr19:55668416
GRCh38:
Chr19:55157048
TNNI3not provided, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A,
Dilated cardiomyopathy 1FF, Hypertrophic cardiomyopathy 7
Uncertain significance
(Sep 9, 2021)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr19:55666207
GRCh38:
Chr19:55154839
TNNI3Hypertrophic cardiomyopathy 7, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A,
Cardiomyopathy, Hypertrophic cardiomyopathy, Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome
Conflicting interpretations of pathogenicity
(Sep 12, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr19:55663296
GRCh38:
Chr19:55151928
TNNI3Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy 7,
Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr19:55667630
GRCh38:
Chr19:55156262
TNNI3R74Pnot provided, Hypertrophic cardiomyopathy, Cardiovascular phenotype,
Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 1FF,
Hypertrophic cardiomyopathy 7
Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr19:55670808
GRCh38:
Chr19:55159440
DNAAF3, DNAAF3-AS1, TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not specified, Primary ciliary dyskinesia,
not provided, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A,
Hypertrophic cardiomyopathy 7
Conflicting interpretations of pathogenicity
(Oct 18, 2022)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr19:55668027
GRCh38:
Chr19:55156659
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 7,
Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A, not specified,
Cardiomyopathy
Conflicting interpretations of pathogenicity
(Jun 1, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr19:55663167
GRCh38:
Chr19:55151799
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not provided, Hypertrophic cardiomyopathy 7,
Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A
Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr19:55665508
GRCh38:
Chr19:55154140
TNNI3V147LCardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy 7,
Dilated cardiomyopathy 1FF, Cardiomyopathy, Hypertrophic cardiomyopathy
Uncertain significance
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr19:55669004
GRCh38:
Chr19:55157636
TNNI3Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy 7,
Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not provided, Cardiomyopathy
Conflicting interpretations of pathogenicity
(Feb 1, 2023)
criteria provided, conflicting interpretations
27.
GRCh37:
Chr19:55669055
GRCh38:
Chr19:55157687
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not provided, Hypertrophic cardiomyopathy 7,
Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A
Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr19:55663239
GRCh38:
Chr19:55151871
TNNI3S199NCardiovascular phenotype, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy,
not provided
Conflicting interpretations of pathogenicity
(Jun 13, 2022)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr19:55665526
GRCh38:
Chr19:55154158
TNNI3R141WCardiovascular phenotype, not provided, Cardiomyopathy,
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Feb 23, 2023)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr19:55666125
GRCh38:
Chr19:55154757
TNNI3T119ICardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A,
Dilated cardiomyopathy 1FF, Hypertrophic cardiomyopathy, not provided,
Cardiovascular phenotype
Uncertain significance
(Mar 23, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr19:55665540
GRCh38:
Chr19:55154172
TNNI3R136QCardiovascular phenotype, not provided, Cardiomyopathy,
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr19:55666189
GRCh38:
Chr19:55154821
TNNI3R98*Hypertrophic cardiomyopathy, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 1FF, not provided,
Cardiomyopathy, Cardiovascular phenotype
Uncertain significance
(Dec 30, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr19:55667989
GRCh38:
Chr19:55156621
TNNI3Cardiovascular phenotype, Dilated cardiomyopathy 1FF, Hypertrophic cardiomyopathy 7,
Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1, not specified,
Cardiomyopathy, Hypertrophic cardiomyopathy
Likely benign
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr19:55665450
GRCh38:
Chr19:55154082
TNNI3S166FCardiovascular phenotype, not provided, Cardiomyopathy,
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Dec 19, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr19:55667684
GRCh38:
Chr19:55156316
TNNI3I56TCardiovascular phenotype, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Dilated cardiomyopathy 1FF, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Uncertain significance
(Dec 13, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr19:55667593
GRCh38:
Chr19:55156225
TNNI3L88fsCardiovascular phenotype, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy,
not specified
Conflicting interpretations of pathogenicity
(Sep 30, 2022)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr19:55666102
GRCh38:
Chr19:55154734
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not specified, Dilated cardiomyopathy 2A,
Hypertrophic cardiomyopathy 7, Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr19:55665439
GRCh38:
Chr19:55154071
TNNI3R170Gnot specified, Dilated cardiomyopathy 1FF, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Oct 14, 2021)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr19:55663261
GRCh38:
Chr19:55151893
TNNI3R192Cnot provided, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 1FF, Restrictive cardiomyopathy,
Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr19:55665463
GRCh38:
Chr19:55154095
TNNI3R162WCardiovascular phenotype, Hypertrophic cardiomyopathy 7, Cardiomyopathy,
Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 1FF,
Hypertrophic cardiomyopathy 7, not provided, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Oct 29, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr19:55668992
GRCh38:
Chr19:55157624
DNAAF3, TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Dilated Cardiomyopathy, Recessive, Familial restrictive cardiomyopathy,
not specified, Primary ciliary dyskinesia, Dilated cardiomyopathy 2A,
Hypertrophic cardiomyopathy 7, Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy
Benign/Likely benign
(Jan 13, 2018)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr19:55667982
GRCh38:
Chr19:55156614
TNNI3Cardiovascular phenotype, Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not specified,
Cardiomyopathy, Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy 7,
Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Oct 16, 2022)
criteria provided, conflicting interpretations
43.
GRCh37:
Chr19:55668029
GRCh38:
Chr19:55156661
TNNI3not specified, Dilated cardiomyopathy 2A, Dilated cardiomyopathy 1FF,
Hypertrophic cardiomyopathy 7, Cardiomyopathy, familial restrictive, 1, not provided,
Hypertrophic cardiomyopathy
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr19:55663278
GRCh38:
Chr19:55151910
TNNI3R186QCardiovascular phenotype, not provided, Cardiomyopathy,
Hypertrophic cardiomyopathy 7, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Sep 29, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr19:55665410
GRCh38:
Chr19:55154042
DNAAF3, TNNI3Cardiovascular phenotype, Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not specified,
Primary ciliary dyskinesia, Cardiomyopathy, Hypertrophic cardiomyopathy 7,
Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Nov 4, 2022)
criteria provided, conflicting interpretations
46.
GRCh37:
Chr19:55665462
GRCh38:
Chr19:55154094
TNNI3R162PCardiovascular phenotype, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Jan 12, 2023)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr19:55665462
GRCh38:
Chr19:55154094
TNNI3R162QCardiovascular phenotype, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Dilated cardiomyopathy 1FF, Hypertrophic cardiomyopathy 7, not provided,
Cardiomyopathy, Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1FF,
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy ...see more
Pathogenic/Likely pathogenic
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr19:55665477
GRCh38:
Chr19:55154109
TNNI3A157VCardiovascular phenotype, not provided, Cardiomyopathy,
Hypertrophic cardiomyopathy 7, Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr19:55665513
GRCh38:
Chr19:55154145
TNNI3R145QCardiovascular phenotype, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Dilated cardiomyopathy 1FF, Hypertrophic cardiomyopathy 7, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 7, Primary familial hypertrophic cardiomyopathy,
Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr19:55665525
GRCh38:
Chr19:55154157
TNNI3R141QCardiovascular phenotype, Dilated cardiomyopathy 1FF, Dilated cardiomyopathy 2A,
Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy 7, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr19:55665578
GRCh38:
Chr19:55154210
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Cardiovascular phenotype, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A,
Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr19:55665589
GRCh38:
Chr19:55154221
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not specified, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 7, Cardiomyopathy, familial restrictive, 1,
Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr19:55666125
GRCh38:
Chr19:55154757
TNNI3T119NCardiovascular phenotype, Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A,
Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 1FF, not specified,
not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 1,
Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy ...see more
Uncertain significance
(Nov 25, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr19:55667578
GRCh38:
Chr19:55156210
TNNI3Cardiovascular phenotype, Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not specified,
not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 7,
Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr19:55668509
GRCh38:
Chr19:55157141
DNAAF3, TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Dilated Cardiomyopathy, Recessive, not specified,
Familial restrictive cardiomyopathy, Primary ciliary dyskinesia, Cardiomyopathy,
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy
Benign/Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr19:55667616
GRCh38:
Chr19:55156248
TNNI3R79CFamilial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Cardiovascular phenotype, not specified,
not provided, Cardiomyopathy, Hypertrophic cardiomyopathy 1,
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr19:55667647
GRCh38:
Chr19:55156279
DNAAF3, TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Cardiovascular phenotype, not specified,
not provided, Primary ciliary dyskinesia, Cardiomyopathy,
Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy 7,
Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Nov 4, 2022)
criteria provided, conflicting interpretations
58.
GRCh37:
Chr19:55667653
GRCh38:
Chr19:55156285
TNNI3Dilated Cardiomyopathy, Recessive, Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Cardiovascular phenotype,
not specified, Familial restrictive cardiomyopathy, not provided,
Cardiomyopathy, Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy 7,
Cardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy ...see more
Benign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr19:55667706
GRCh38:
Chr19:55156338
TNNI3Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, not provided, not specified,
Cardiomyopathy, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A,
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Aug 23, 2022)
criteria provided, conflicting interpretations
60.
GRCh37:
Chr19:55667958
GRCh38:
Chr19:55156590
DNAAF3, TNNI3Dilated Cardiomyopathy, Recessive, Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Familial restrictive cardiomyopathy,
not specified, Primary ciliary dyskinesia, Cardiomyopathy,
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr19:55665584
GRCh38:
Chr19:55154216
DNAAF3, TNNI3, TNNT1Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Nemaline Myopathy, Recessive, not specified,
Primary ciliary dyskinesia, Cardiomyopathy, Primary familial hypertrophic cardiomyopathy,
Hypertrophic cardiomyopathy 7, Cardiomyopathy, familial restrictive, 1, Dilated cardiomyopathy 2A,
Hypertrophic cardiomyopathy
Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
62.
GRCh37:
Chr19:55668465
GRCh38:
Chr19:55157097
TNNI3R21CCardiovascular phenotype, Hypertrophic cardiomyopathyPathogenic
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr19:55665398-55665400
GRCh38:
Chr19:55154030-55154032
TNNI3K183delHypertrophic cardiomyopathy 7Pathogenic
(Aug 1, 1997)
no assertion criteria provided
64.
GRCh37:
Chr19:55663228
GRCh38:
Chr19:55151860
TNNI3G203SHypertrophic cardiomyopathy 7Pathogenic
(Aug 1, 1997)
no assertion criteria provided
65.
GRCh37:
Chr19:55665415
GRCh38:
Chr19:55154047
TNNI3K178EHypertrophic cardiomyopathy 7Pathogenic
(Mar 18, 2020)
criteria provided, single submitter
66.
GRCh37:
Chr19:55663266
GRCh38:
Chr19:55151898
TNNI3D190GCardiomyopathy, familial restrictive, 1, Hypertrophic cardiomyopathy 7Pathogenic
(Jan 1, 2003)
no assertion criteria provided
67.
GRCh37:
Chr19:55663249
GRCh38:
Chr19:55151881
TNNI3D196NCardiovascular phenotype, Dilated cardiomyopathy 2A, Cardiomyopathy, familial restrictive, 1,
Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 1FF, not provided,
Cardiomyopathy, Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Pathogenic/Likely pathogenic
(Dec 29, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr19:55667607
GRCh38:
Chr19:55156239
TNNI3P82SFamilial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome, Dilated Cardiomyopathy, Recessive, Cardiovascular phenotype,
Dilated cardiomyopathy 1FF, Hypertrophic cardiomyopathy 7, Dilated cardiomyopathy 2A,
Cardiomyopathy, familial restrictive, 1, Cardiomyopathy, Amyloidogenic transthyretin amyloidosis,
Familial restrictive cardiomyopathy, not providednot specified,
Cardiomyopathy, Hypertrophic cardiomyopathy 7, Cardiomyopathy, familial restrictive, 1,
Dilated cardiomyopathy 2A, Hypertrophic cardiomyopathy, ...see more
Benign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr19:55663219
GRCh38:
Chr19:55151851
TNNI3K206QHypertrophic cardiomyopathy 7Pathogenic
(Aug 1, 1997)
no assertion criteria provided
70.
GRCh37:
Chr19:55665514
GRCh38:
Chr19:55154146
TNNI3R145GCardiovascular phenotype, not provided, Cardiomyopathy,
Hypertrophic cardiomyopathy 7, Hypertrophic cardiomyopathy
Pathogenic
(Dec 17, 2021)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination